Skip to content

Effects of Triclosan coated suture on the surgical site infection in gastric cancer surgery patients

Effects of Triclosan coated suture on the surgical site infection in gastric cancer surgery patients

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CRIS
Registry ID
KCT0000209
Enrollment
900
Registered
2011-10-27
Start date
2009-12-21
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : A nosocomial (or hospital acquired) infection is that a patient is infected in the hospital setting due to exposure to pathogenic microorganisms or because of endogenous microorganism

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with gastric surgery who are scheduled to receive surgery 2) Patients with 18 years of age and above 3) Patients who have voluntarily signed written consent forms

Exclusion criteria

Exclusion criteria: 1) Patients with contaminated wounds 2) Patients with impaired wound healing function (eg, suffering from AIDS) 3) Patients who have to take other antibiotics during the trial period 4) Pregnant women 5) Patient who suffer from other disorders that the investigators believe could distort the clinical trial results 6) Patient who the investigators believe will be unable to complete the clinical trial

Design outcomes

Primary

MeasureTime frame
Surgical site infection

Secondary

MeasureTime frame
status of wound healing

Countries

Korea, Republic of

Contacts

Public ContactSeung Jong Oh

Samsung Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026